Webinar: Patient-Centric Drug Formulation Principles

Focused on:

Date: 23th October

Days old: 4488

Time: 3PM London / 10AM New York

Watch Now for FREE

Learn more about Business Review Webinars

Already Registered?

If you have previously registered for this event, please login below:

Register

All fields below are required.

First Name

Last Name

Telephone

Company

Job Title

City

Country

I accept that the data provided on this form will be processed, stored and used in accordance with the terms set out in our Privacy policy and T&C’s.

Optimizing Regulatory and Product Development Strategies for Oral Pediatric and Geriatric Products

While advancements in drug delivery technologies have constantly improved the efficacy of therapies, there is still an unmet need to provide patient-centric drug delivery solutions for the Pediatric and Geriatric patient populations. Progress has been made in order to meet the specific requirements for pediatric patients based on U.S. FDA and EU pediatric regulations, facilitating the development and availability of medicines for children (birth to <18 years). Conversely, as a result of a significant demographic change, a substantial proportion of elderly individuals increasingly require specifically designed medication. The industry faces increasing technological challenges to provide intelligent drug delivery solutions that can be designed to meet these patient-centric needs.

This presentation will address the challenge of therapeutic principles for the Pediatric and Geriatric populations illustrating the versatility of drug delivery solutions in the field of oral dosage forms. Case studies focusing on taste-masked oral formulations and oral disintegrating tablets, core competencies of Aptalis, highlight the potency of these formulation concepts and provide insight into regulatory and patent exclusivity pathways for new formulations that can enable successful commercialization.

Register now to join this upcoming discussion about formulation challenges and examine how Aptalis can develop versatile drug delivery solutions for your products.

Presented by

Robert Becker PhD,

Chief Research Officer, Aptalis Pharma

Dr. Robert Becker is currently Chief Research Officer, Aptalis Pharma and leads the global R&D development for the organization. He has 28 years of experience, holding leading positions at Boehringer Ingelheim, Ely Lilly & Co., and Biogen Idec, and an in-depth knowledge in Formulation Development and Analytical characterization of APIs, dosage forms, delivery systems, scale up and GMP manufacturing. Dr. Becker received his PhD from the Technical University of Munich and the Max Planck Institute of Biochemistry with the scientific focus on physico-chemical characterization of macromolecules.

Carsten Timpe, PhD,

Team Leader Formulation, Senior Principal Scientist - Hoffmann La Roche AG

Dr. Carsten Timpe is currently Team Leader Formulation/Senior Principcal Scientist at Hoffmann La Roche AG in Basel, Switzerland, focusing on early drug development. Previously, he held positions at Novartis, Lilly, and Schering/Jenapharm. Dr. Timpe has 20 years of experience in solid dosage form development from early to late stage and is the inventor/co-inventor of multiple international formulation patents. Dr. Timpe completed his Ph.D. thesis in Pharmaceutical Chemistry at the Philipps University Marburg, Germany.

Download Slides

Please login to download the slides

Key Learning Objectives

Challenges of formulation development for effective patient-centric drug products
Oral drug delivery needs for Pediatric and Geriatric patient populations
Review of drug delivery solutions to meet patient specific needs
Case studies on taste-masked oral formulations and oral disintegrating tablets

Audience

Chief Officers / Executive Management
Managing Directors
Pharmaceutical R&D Management
Formulation Scientists
Business Development Management
Outsourcing Management
Business continuity Managers